LEO Pharma Investigational Site

Saskatoon, Saskatchewan S7K 2C1

1 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Lichen Sclerosus

Studies at this site

• A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus — Recruiting now
• Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). — Completed
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND — Completed